Jaguar Health Inc.
JAGX | NASDAQ
$0.87
-$0.75 (-46.30%)
Nov 2, 2026, 2:28 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.04 | -0.19 | -0.03 | -0.06 | -0.29 | -0.27 |
PEG Ratio | 0 | 0 | 0 | 0 | 0 | 0 |
PS Ratio | 0.19 | 0.64 | 0.12 | 0.24 | 3.58 | 1.12 |
PB Ratio | -0.13 | 1.02 | 0.23 | -4.34 | 1.33 | 0.61 |
P/FCF Ratio | 0.38 | -0.25 | -0.04 | -0.08 | -0.44 | -0.69 |
P/OCF Ratio | 0.37 | -0.25 | -0.04 | -0.09 | -0.44 | -0.69 |
OCF/S Ratio | 50.37 | -251.38 | -340.56 | -276.88 | -806.69 | -162.79 |
Debt / Equity Ratio | -2.52 | 5.01 | 7.48 | -53.02 | 2.53 | 0.94 |
Quick Ratio | 0.29 | 1.11 | 1.34 | 0.50 | 1.52 | 1.14 |
Current Ratio | 0.50 | 1.63 | 2 | 0.74 | 1.84 | 1.35 |
Asset Turnover | 0.30 | 0.22 | 0.19 | 0.25 | 0.08 | 0.22 |
Interest Coverage | 673.25 | -133.47 | -5.37 | -2.70 | -4.83 | -9.54 |
Return on Equity | 309.06% | -528.37% | -832.49% | 7.22K% | -452.98% | -196.54% |
Return on Assets | -139.43% | -72.05% | -81.36% | -100% | -98.74% | -78.91% |
Return on Invested Capital | -178.29% | -66.94% | -81.66% | -102.80% | -98.76% | -79.75% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 67.21% | 83.27% | 79.13% | 83.11% | 46.18% | 65.05% |
Net Profit Margin | -464.20% | -329.30% | -423.11% | -396.91% | -1.21K% | -360.25% |
Pretax Profit Margin | -469.09% | -335.79% | -429.27% | -404.78% | -1.21K% | -360.25% |
Operating Profit Margin | -391.87% | -263.76% | -351.31% | -287.85% | -939.05% | -283.93% |
FCF Margin | 50.15% | -253.36% | -340.56% | -290.89% | -806.83% | -162.87% |
EBITDA Margin | -449.38% | -313.65% | -335.62% | -279.19% | -977.30% | -306.20% |
Add to Watchlist
Select watchlists to add or remove JAGX